Belite Bio, Inc (BLTE) Enterprise Value (2021 - 2025)

Belite Bio (BLTE) has reported Enterprise Value for 5 consecutive years, with -$476.8 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Enterprise Value fell 239.1% year-over-year to -$476.8 million; the TTM figure through Dec 2025 stood at -$476.8 million (down 239.1% YoY), while the FY2025 annual figure was -$476.8 million, down 239.1% from the prior year.
• Enterprise Value came in at -$476.8 million for Q4 2025 at Belite Bio, down from -$157.0 million in the prior quarter.
• The five-year high for Enterprise Value was -$17.3 million in Q4 2021, with the low at -$476.8 million in Q4 2025.
• Average Enterprise Value over 5 years is -$153.7 million, with a median of -$114.4 million recorded in 2023.
• Across the five-year window, Enterprise Value plunged 59.49% in 2024 and sank 239.1% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$17.3 million in 2021, then tumbled by 142.67% to -$42.1 million in 2022, then plunged by 109.45% to -$88.2 million in 2023, then slumped by 59.49% to -$140.6 million in 2024, then tumbled by 239.1% to -$476.8 million in 2025.
• According to Business Quant data, Enterprise Value over the past three periods registered -$476.8 million, -$157.0 million, and -$140.6 million for Q4 2025, Q3 2025, and Q4 2024 respectively.